You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-Twist antibodySee all Twist primary antibodies ...
  • Description
    Rabbit polyclonal to Twist
  • Tested applicationsEMSA, IHC-P, WB, ICC/IF more details
  • Species reactivity
    Reacts with: Rat, Human
    Predicted to work with: Mouse, Chicken, Chimpanzee
  • Immunogen

    Synthetic peptide: PADDSLSNSEEEPDRQ conjugated to KLH by a C-terminal Cysteine residue linker, corresponding to amino acids 12-27 of Human Twist

  • Positive controlOsteosarcoma MG-63 cells. Human melanoma Mel15 cells. 293T cells expressing recombinant human Twist1.

Properties

Applications

Our Abpromise guarantee covers the use of ab50581 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
EMSA EMSA: Use at an assay dependent concentration. PubMed: 21931630
IHC-P IHC-P: 1/500.
WB WB: Use a concentration of 0.5 - 1 µg/ml. Detects a band of approximately 26 kDa (predicted molecular weight: 21 kDa).
ICC/IF ICC/IF: Use a concentration of 1 - 2 µg/ml.

Target

  • FunctionActs as a transcriptional regulator. Inhibits myogenesis by sequestrating E proteins, inhibiting trans-activation by MEF2, and inhibiting DNA-binding by MYOD1 through physical interaction. This interaction probably involves the basic domains of both proteins. Also represses expression of proinflammatory cytokines such as TNFA and IL1B. Regulates cranial suture patterning and fusion. Activates transcription as a heterodimer with E proteins. Regulates gene expression differentially, depending on dimer composition. Homodimers induce expression of FGFR2 and POSTN while heterodimers repress FGFR2 and POSTN expression and induce THBS1 expression. Heterodimerization is also required for osteoblast differentiation.
  • Tissue specificitySubset of mesodermal cells.
  • Involvement in diseaseDefects in TWIST1 are a cause of Saethre-Chotzen syndrome (SCS) [MIM:101400]; also known as acrocephalosyndactyly type 3 (ACS3). SCS is a craniosynostosis syndrome characterized by coronal synostosis, brachycephaly, low frontal hairline, facial asymmetry, hypertelorism, broad halluces, and clinodactyly.
    Defects in TWIST1 are the cause of Robinow-Sorauf syndrome (RSS) [MIM:180750]; also known as craniosynostosis-bifid hallux syndrome. RSS is an autosomal dominant defect characterized by minor skull and limb anomalies which is very similar to Saethre-Chotzen syndrome.
    Defects in TWIST1 are the cause of craniosynostosis type 1 (CRS1) [MIM:123100]. Craniosynostosis consists of premature fusion of one or more cranial sutures, resulting in an abnormal head shape.
  • Sequence similaritiesContains 1 basic helix-loop-helix (bHLH) domain.
  • Cellular localizationNucleus.
  • Target information above from: UniProt accession Q15672 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      ACS3 antibodyB-HLH DNA binding protein antibodybHLHa38 antibody
      BPES2 antibodyBPES3 antibodyClass A basic helix-loop-helix protein 38 antibodyCRS1 antibodyH-twist antibodyOTTHUMP00000116043 antibodySCS antibodyTWIST antibodyTwist homolog 1 (Drosophila) antibodyTwist homolog 1 antibodyTWIST homolog of drosophila antibodyTwist related protein 1 antibodyTwist-related protein 1 antibodyTwist1 antibodyTWST1_HUMAN antibody
    see all

Anti-Twist antibody images

  • Human melanoma Mel15 cells were fixed and permeabilized with 4% paraformaldehyde followed by 0.1% Triton X-100. Fixed cells were stained with 2 µg/ml ab50581. The antibody was developed with Goat Anti-Rabbit IgG, Cy3 conjugate.
  • ab50581 staining Twist in murine brain tissue by Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections). Tissue was fixed with paraformaldehyde and a heat mediated antigen retrieval step was performed using citric acid buffer pH 6.1. Samples were then blocked with 0.5% BSA for 30 minutes at room temperature followed by incubation with the primary antibody at a 1/500 dilution for 2 hours. A biotin-conjugated secondary antibody was used at a 1/100 dilution.
  • ab50581 staining Twist in human glioblastoma cells by Immunocytochemistry/ Immunofluorescence. The cells were fixed in paraformaldehyde, permeabilised in 0.1% Triton X-100 and then blocked using 0.5% BSA for 20 minutes. Samples were then incubated with primary antibody at 1/50 for 16 hours at 4°C. The secondary antibody used was a goat anti-rabbit IgG conjugated to Cy3® used at a 1/400 dilution.

References for Anti-Twist antibody (ab50581)

This product has been referenced in:
  • Chen Z  et al. The Iron Chelators Dp44mT and DFO Inhibit TGF-ß-Induced Epithelial-Mesenchymal Transition via Up-Regulation of N-myc Downstream Regulated Gene 1 (NDRG1). J Biol Chem : (2012). WB . Read more (PubMed: 22453918) »
  • Dave N  et al. Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J Biol Chem 286:12024-32 (2011). WB ; Mouse . Read more (PubMed: 21317430) »

See all 7 Publications for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Western blot
Sample Pig Cell lysate - whole cell (PAE cells)
Loading amount 75 µg
Specification PAE cells
Gel Running Conditions Reduced Denaturing (15% gel)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: RT°C
Username

Verified customer

Submitted Jan 25 2013

Application Western blot
Sample Mouse Cell lysate - whole cell (293T - wild typoe andTwist transfected cells)
Loading amount 40 µg
Specification 293T - wild typoe andTwist transfected cells
Gel Running Conditions Reduced Denaturing (15)
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: RT°C
Username

Verified customer

Submitted Dec 18 2012

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (Prostate cancer)
Specification Prostate cancer
Fixative Paraformaldehyde
Permeabilization Yes - 0.2% Triton X-100
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Aug 29 2011

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (human glioblastoma cell line)
Specification human glioblastoma cell line
Fixative Paraformaldehyde
Permeabilization Yes - Tritonx100 0.1% in PBS
Blocking step BSA as blocking agent for 20 minute(s) · Concentration: 0.5% · Temperature: RT°C
Username

Verified customer

Submitted Apr 20 2011

Application Western blot
Sample Human Cell lysate - whole cell (A293T)
Loading amount 20 µg
Specification A293T
Treatment Transfect with human Twist expression plasmid for 24 hours
Gel Running Conditions Non-reduced Denaturing (12)
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Nov 23 2010

Application Western blot
Sample Mouse Cell lysate - whole cell (choroid plexus cell line and C6 mouse glioma cell)
Loading amount 100 µg
Specification choroid plexus cell line and C6 mouse glioma cell
Gel Running Conditions Reduced Denaturing (12.5 % SDS gel)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: RT°C
Username

Verified customer

Submitted Sep 30 2010

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Specification brain
Sample Mouse Tissue sections (brain)
Fixative Paraformaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: pH 6.1 citrit acid buffer
Permeabilization No
Blocking step BSA as blocking agent for 30 minute(s) · Concentration: 0.5% · Temperature: RT°C
Username

Verified customer

Submitted Sep 29 2010

Application Immunocytochemistry/ Immunofluorescence
Sample Rat Cell (choroid plexus cell line)
Specification choroid plexus cell line
Fixative Paraformaldehyde
Permeabilization Yes - 0.1% Triton X 100 in PBS
Blocking step BSA as blocking agent for 30 minute(s) · Concentration: 0.5% · Temperature: RT°C
Username

Verified customer

Submitted Sep 10 2010

Abreviews
Application Western blot
Sample Mouse Cell lysate - whole cell (Mammary epithelial cells)
Loading amount 1500 cells
Specification Mammary epithelial cells
Gel Running Conditions Non-reduced Denaturing (15% gel)
Blocking step Casein Block as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 0.1% · Temperature: 25°C
Username

Verified customer

Submitted Jul 15 2010

Application Western blot
Sample Human Tissue lysate - whole (Breast tissue)
Loading amount 10 µg
Specification Breast tissue
Gel Running Conditions Reduced Denaturing (8)
Blocking step (agent) for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 20°C
Username

Verified customer

Submitted Sep 29 2009



Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"